The Value of Pulmonary Function Testing in Bone Marrow Transplantation
Back to listIntroduction
The current guidelines from the international literature, which have been incorporated into the Bone Marrow Transplant (BMT) protocols of specialized health care facilities, recommend that pulmonary function tests (PFTs) be performed before transplantation and as a posttransplant follow-up evaluation. The general belief is that PFTs in the pretransplant period assist in establishing a reference baseline for posttransplant PFT measurements as well as identify those patients with abnormal pretransplant PFTs. Testing may be useful in expediting the diagnosis of posttransplant noninfectious pulmonary complications allowing for early intervention and the consequent increase in patient survival. However, the question remains whether there is sufficient reliable data to support and validate this practice. In this article we reviewed the publications that have assessed the use of pretransplant PFTs in bone marrow transplant patients and determined their validity and usefulness in identifying those patients who are at high risk for developing posttransplant noninfectious pulmonary complications. We conducted a PubMed search to identify all the publications that have investigated the role of pretransplant pulmonary functions tests in predicting posttransplant pulmonary complication in patients undergoing bone marrow transplant. These articles are analyzed and their significant findings were summarized below.
Abstract
INTRODUCTION
The pre- and postbone marrow transplant pulmonary functions testing are widely used as standard clinical practice. However, whether there is sufficient reliable data to support and validate this practice is not confirmed.
OBJECTIVE
In this article we will review the publications that have assessed the role of pretransplant pulmonary functions tests for bone marrow transplant patients in identifying those patients who are at high risk for developing posttransplant noninfectious pulmonary complications.
METHODS
PubMed search to identify the publications that have investigated the role of pretransplant pulmonary functions tests in predicting posttransplant pulmonary complication in patients undergoing bone marrow transplant.
RESULTS
Several small studies suggest a risk of posttransplant complications associated with pretransplant obstructive patterns.
CONCLUSION
Large randomized control trials examining pretransplant lung function are needed, including both nonmyeloablative and myeloablative conditioning regimens, to determine how pretransplant pulmonary function data can be applied clinically to reduce patient risk for significant pulmonary complications and mortality.
Keywords
pulmonary function testing, bone marrow transplant, pulmonary complications
Other Articles
- Non-Small Cell Lung Cancer: Screening, Diagnosis, and Staging
- Fiber Width as a Determinant of Mesothelioma Induction and Threshold—Bolivian Crocidolite: Epidemiological Evidence from Bolivia—Mesothelioma Demography and Exposure Pathways
- Review: Respiratory Virus Infection in Immunocompromised Children
- Maternal and Fetal Perinatal Outcomes Among Pregnant Women Hospitalized With Respiratory Diseases in Assiut University Hospital
- Noninvasive Ventilation for Weaning and Post Extubation Failure
